Avoro Capital Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,497,042
| Closed | -$17M | – | 37 |
|
|
2018
Q3 | $17M | Hold |
4,497,042
| – | – | 0.78% | 23 |
|
|
2018
Q2 | $14M | Sell |
4,497,042
-195,301
| -4% | -$609K | 0.54% | 30 |
|
|
2018
Q1 | $11.2M | Buy |
4,692,343
+800,000
| +21% | +$1.91M | 0.54% | 30 |
|
|
2017
Q4 | $15.2M | Sell |
3,892,343
-743,402
| -16% | -$2.91M | 0.99% | 24 |
|
|
2017
Q3 | $11.7M | Buy |
4,635,745
+831,000
| +22% | +$2.09M | 0.91% | 24 |
|
|
2017
Q2 | $10.5M | Hold |
3,804,745
| – | – | 1.33% | 22 |
|
|
2017
Q1 | $7.42M | Buy |
3,804,745
+2,663,596
| +233% | +$5.19M | 0.95% | 27 |
|
|
2016
Q4 | $1.2M | Buy |
+1,141,149
| New | +$1.2M | 0.24% | 36 |
|
|
2015
Q1 | – | Sell |
-550,670
| Closed | -$1.64M | – | 35 |
|
|
2014
Q4 | $1.64M | Buy |
+550,670
| New | +$1.64M | 1.11% | 22 |
|